exploring frontiers of bioscience
The Paul G. Allen Frontiers Group explores the landscape of science to identify and invest in pioneers with ideas that will create new knowledge and make the world better. Through continuous dialogue with scientists and visionaries around the world, the Frontiers Group will uncover novel ideas in bioscience with the potential to transform fields. The Frontiers Group will help to create new ways of doing science, new ways of solving problems, and foster a creative community that imagines and creates the future.
We engage with scientists and visionaries around the world to uncover and make visible emerging frontiers and new directions in science. We convene creative partners in novel ways to imagine possible futures.
Funding new ideas
We invest in investigators and centers for frontier explorations that lead to new fundamental insights and produce important solutions with big impact.
We link ideas across the landscape of quantitative fields now addressing bioscience research and seek out creative approaches that span disciplines.
Researchers receive $1.5 million each to study extracellular matrix for cardiovascular research
August 9, 2017
American Heart Association, The Paul G. Allen Frontiers Group fund research seeking next breakthrough
Allen Distinguished Investigator stores frames of a movie in living cells
July 12, 2017
A team jointly led by Allen Distinguished Investigator Jeffrey D. Macklis, at Harvard University, has demonstrated the enormous potential of DNA as a medium for storing information within living systems by encoding black and white images and frames of a short movie in the genome of a population of E. coli bacteria.
The Paul G. Allen Frontiers Group announces two new Allen Discovery Centers
July 5, 2017
The Paul G. Allen Frontiers Group today announced the creation of two new Allen Discovery Centers, one at UW Medicine and one at Boston Children's Hospital and Harvard Medical School.